Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Combined analysis of MGMT methylation and dynamic-susceptibility-contrast MRI for the distinction between early and pseudo-progression in glioblastoma patients.

Bani-Sadr A, Berner LP, Barritault M, Chamard L, Bidet CM, Eker OF, Hermier M, Guyotat J, Jouanneau E, Meyronet D, Gouttard S, D'Hombres A, Iziquierdo C, Honnorat J, Berthezène Y, Ducray F.

Rev Neurol (Paris). 2019 Jun 14. pii: S0035-3787(18)30736-7. doi: 10.1016/j.neurol.2019.01.400. [Epub ahead of print]

PMID:
31208813
2.

The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers?

Fenouil T, Fourier A, Quadrio I, Streichenberger N, Bernardini S, Zima T, Perret-Liaudet A, Meyronet D.

Clin Biochem. 2019 Jun 10. pii: S0009-9120(19)30345-5. doi: 10.1016/j.clinbiochem.2019.06.004. [Epub ahead of print] Review.

PMID:
31194969
3.

Anatomical and Histological Analysis of a Complex Structure Too Long Considered a Simple Ligament: The Filum Terminale.

Picart T, Barritault M, Simon E, Robinson P, Barrey C, Meyronet D, Mertens P.

World Neurosurg. 2019 Sep;129:e464-e471. doi: 10.1016/j.wneu.2019.05.184. Epub 2019 May 29.

PMID:
31150849
4.

Spectral complexity of 5-ALA induced PpIX fluorescence in guided surgery: a clinical study towards the discrimination of healthy tissue and margin boundaries in high and low grade gliomas.

Alston L, Mahieu-Williame L, Hebert M, Kantapareddy P, Meyronet D, Rousseau D, Guyotat J, Montcel B.

Biomed Opt Express. 2019 Apr 18;10(5):2478-2492. doi: 10.1364/BOE.10.002478. eCollection 2019 May 1.

5.

A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas.

Bret D, Chappuis V, Poncet D, Ducray F, Silva K, Mion F, Vasiljevic A, Ferraro-Peyret C, Mottolese C, Leblond P, Gabut M, Frappaz D, Streichenberger N, Meyronet D, Bringuier PP, Barritault M.

Mol Diagn Ther. 2019 Aug;23(4):537-545. doi: 10.1007/s40291-019-00403-3.

PMID:
31087282
6.

Simultaneous occurrence of giant cell arteritis and cerebral amyloid angiopathy.

Fouret M, Jamilloux Y, Szathmari A, Vasiljevic A, Meyronet D, Ducray F, Seve P.

Rheumatology (Oxford). 2019 Aug 1;58(8):1503-1505. doi: 10.1093/rheumatology/kez099. No abstract available.

PMID:
30927437
7.

Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis.

Chefdeville A, Treilleux I, Mayeur ME, Couillault C, Picard G, Bost C, Mokhtari K, Vasiljevic A, Meyronet D, Rogemond V, Psimaras D, Dubois B, Honnorat J, Desestret V.

Acta Neuropathol Commun. 2019 Mar 11;7(1):38. doi: 10.1186/s40478-019-0693-7.

8.

Medulloblastomas in adolescents and adults - Can the pediatric experience be extrapolated?

Frappaz D, Faure-Conter C, Bonneville Levard A, Barritault M, Meyronet D, Sunyach MP.

Neurochirurgie. 2018 Dec 13. pii: S0028-3770(18)30361-8. doi: 10.1016/j.neuchi.2018.10.007. [Epub ahead of print] Review.

PMID:
30554773
9.

The molecular landscape of glioma in patients with Neurofibromatosis 1.

D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A.

Nat Med. 2019 Jan;25(1):176-187. doi: 10.1038/s41591-018-0263-8. Epub 2018 Dec 10.

PMID:
30531922
10.

Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations.

Izquierdo C, Barritault M, Poncet D, Cartalat S, Joubert B, Bruna J, Jouanneau E, Guyotat J, Vasiljevic A, Fenouil T, Berthezène Y, Honnorat J, Meyronet D, Ducray F.

Neurosurgery. 2019 Sep 1;85(3):E448-E456. doi: 10.1093/neuros/nyy513.

PMID:
30407589
11.

Are molecular subgroups of medulloblastomas really prognostic?

Frappaz D, Faure-Conter C, Meyronet D, Levard-Bonneville A, Beuriat PA, Sunyach MP, Barritault M.

Curr Opin Neurol. 2018 Dec;31(6):747-751. doi: 10.1097/WCO.0000000000000626. Review.

PMID:
30300240
12.

Molecular classification of adult gliomas: recent advances and future perspectives.

Barritault M, Meyronet D, Ducray F.

Curr Opin Oncol. 2018 Nov;30(6):375-382. doi: 10.1097/CCO.0000000000000482. Review.

PMID:
30148717
13.

Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Desestret V, Honnorat J.

J Neurol. 2018 Oct;265(10):2190-2200. doi: 10.1007/s00415-018-8970-0. Epub 2018 Jul 12.

PMID:
30003358
14.

Returning to work after multimodal treatment in glioblastoma patients.

Starnoni D, Berthiller J, Idriceanu TM, Meyronet D, d'Hombres A, Ducray F, Guyotat J.

Neurosurg Focus. 2018 Jun;44(6):E17. doi: 10.3171/2018.3.FOCUS1819.

PMID:
29852767
15.

Embryonal tumor of posterior cerebral fossa: false-negative diagnosis by fetal MRI related to misinterpretation of decreased apparent diffusion coefficient.

Cabet S, Meyronet D, Fichez A, di Rocco F, Gauthier-Moulinier H, Guibaud L.

Ultrasound Obstet Gynecol. 2019 Apr;53(4):551-553. doi: 10.1002/uog.19095. No abstract available.

PMID:
29786163
16.

Thoracic spine intra- and extradural dumbbell-shaped meningioma: Case report and extensive review of the literature with 21 cases.

N'da H, Dauleac C, Toquart A, Afathi M, Meyronet D, Barrey C.

Neurochirurgie. 2018 Jun;64(3):206-210. doi: 10.1016/j.neuchi.2018.03.001. Epub 2018 May 3. Review.

PMID:
29730052
17.

Surgical approach for suprasellar hemangioblastomas preserving the pituitary stalk: Review of the literature and report of a further case.

Alshafai N, Maduri R, Shail M, Chirchiglia D, Meyronet D, Signorelli F.

Clin Neurol Neurosurg. 2018 May;168:147-152. doi: 10.1016/j.clineuro.2018.03.010. Epub 2018 Mar 10. Review.

PMID:
29550691
18.

Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.

Bruno A, Labreche K, Daniau M, Boisselier B, Gauchotte G, Royer-Perron L, Rahimian A, Lemoine F, de la Grange P, Guégan J, Bielle F, Polivka M, Adam C, Meyronet D, Figarella-Branger D, Villa C, Chrétien F, Eimer S, Davi F, Rousseau A, Houillier C, Soussain C, Mokhtari K, Hoang-Xuan K, Alentorn A.

Neuro Oncol. 2018 Jul 5;20(8):1092-1100. doi: 10.1093/neuonc/noy019.

19.

[Neuropathology of sudden infant death syndrome: Review of the literature and proposal of a protocol for neuropathological examination].

Delteil C, Meyronet D, Maues de Paula A, Jouvet A, Piercecchi-Marti MD.

Ann Pathol. 2018 Apr;38(2):103-109. doi: 10.1016/j.annpat.2018.01.001. Epub 2018 Feb 9. Review. French.

PMID:
29429858
20.

Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.

Bronnimann C, Izquierdo C, Cartalat S, Thomas L, Joubert B, Delpech L, Barritault M, Meyronet D, Honnorat J, Ducray F.

J Neurooncol. 2018 May;138(1):141-145. doi: 10.1007/s11060-018-2780-1. Epub 2018 Jan 31.

PMID:
29388033
21.

Liponeurocytoma of the Cerebellopontine Angle.

Chiaramonte C, Rabaste S, Jacquesson T, Meyronet D, Cotton F, Jouanneau E, Berhouma M.

World Neurosurg. 2018 Apr;112:18-24. doi: 10.1016/j.wneu.2018.01.012. Epub 2018 Jan 8. Review.

PMID:
29325939
22.

Characteristics of cerebellar glioblastomas in adults.

Picart T, Barritault M, Berthillier J, Meyronet D, Vasiljevic A, Frappaz D, Honnorat J, Jouanneau E, Poncet D, Ducray F, Guyotat J.

J Neurooncol. 2018 Feb;136(3):555-563. doi: 10.1007/s11060-017-2682-7. Epub 2017 Dec 1.

PMID:
29196927
23.

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Izquierdo C, Alentorn A, Idbaih A, Simó M, Kaloshi G, Ricard D, Barritault M, Meyronet D, Bruna J, Honnorat J, Delattre JY, Ducray F.

J Neurooncol. 2018 Feb;136(3):533-539. doi: 10.1007/s11060-017-2677-4. Epub 2017 Nov 15.

PMID:
29143276
24.

Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.

Bielle F, Di Stefano AL, Meyronet D, Picca A, Villa C, Bernier M, Schmitt Y, Giry M, Rousseau A, Figarella-Branger D, Maurage CA, Uro-Coste E, Lasorella A, Iavarone A, Sanson M, Mokhtari K.

Brain Pathol. 2018 Sep;28(5):674-683. doi: 10.1111/bpa.12563. Epub 2017 Nov 21.

PMID:
28976058
25.

Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.

Quillien V, Lavenu A, Ducray F, Meyronet D, Chinot O, Fina F, Sanson M, Carpentier C, Karayan-Tapon L, Rivet P, Entz-Werle N, Legrain M, Zalcman EL, Levallet G, Escande F, Ramirez C, Chiforeanu D, Vauleon E, Figarella-Branger D.

Cancer Biomark. 2017 Dec 6;20(4):435-441. doi: 10.3233/CBM-170191.

26.

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.

Royet A, Broutier L, Coissieux MM, Malleval C, Gadot N, Maillet D, Gratadou-Hupon L, Bernet A, Nony P, Treilleux I, Honnorat J, Liebl D, Pelletier L, Berger F, Meyronet D, Castets M, Mehlen P.

Oncotarget. 2017 Apr 4;8(14):23750-23759. doi: 10.18632/oncotarget.16077.

27.

Characteristics of H3 K27M-mutant gliomas in adults.

Meyronet D, Esteban-Mader M, Bonnet C, Joly MO, Uro-Coste E, Amiel-Benouaich A, Forest F, Rousselot-Denis C, Burel-Vandenbos F, Bourg V, Guyotat J, Fenouil T, Jouvet A, Honnorat J, Ducray F.

Neuro Oncol. 2017 Aug 1;19(8):1127-1134. doi: 10.1093/neuonc/now274.

28.

Intraoperative Probe-Based Confocal Laser Endomicroscopy in Surgery and Stereotactic Biopsy of Low-Grade and High-Grade Gliomas: A Feasibility Study in Humans.

Pavlov V, Meyronet D, Meyer-Bisch V, Armoiry X, Pikul B, Dumot C, Beuriat PA, Signorelli F, Guyotat J.

Neurosurgery. 2016 Oct;79(4):604-12. doi: 10.1227/NEU.0000000000001365.

PMID:
27643918
29.

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.

Tabouret E, Nguyen AT, Dehais C, Carpentier C, Ducray F, Idbaih A, Mokhtari K, Jouvet A, Uro-Coste E, Colin C, Chinot O, Loiseau H, Moyal E, Maurage CA, Polivka M, Lechapt-Zalcman E, Desenclos C, Meyronet D, Delattre JY, Figarella-Branger D; For POLA Network.

Acta Neuropathol. 2016 Oct;132(4):625-34. doi: 10.1007/s00401-016-1611-8. Epub 2016 Aug 29.

PMID:
27573687
30.

MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.

Bonnin N, Armandy E, Carras J, Ferrandon S, Battiston-Montagne P, Aubry M, Guihard S, Meyronet D, Foy JP, Saintigny P, Ledrappier S, Jung A, Rimokh R, Rodriguez-Lafrasse C, Poncet D.

Oncotarget. 2016 Jul 12;7(28):44023-44038. doi: 10.18632/oncotarget.9829.

31.

Anti-NMDA receptor antibody encephalitis and neuroendocrine pancreatic tumor: Causal link?

Afanasiev V, Brechemier ML, Boisseau W, Ducoudray R, Mayeur ME, Meyronet D, Peskine A, Desestret V, Psimaras D.

Neurology. 2016 Jul 5;87(1):112-3. doi: 10.1212/WNL.0000000000002809. Epub 2016 Jun 8. No abstract available.

32.

Dynamic susceptibility contrast perfusion imaging in biopsy-proved adult medulloblastoma.

Theillac M, Meyronet D, Savatovsky J, Makris N, Hannoun S, Grand S, Cotton F.

J Neuroradiol. 2016 Oct;43(5):317-24. doi: 10.1016/j.neurad.2016.05.002. Epub 2016 Jun 1.

PMID:
27262628
33.

Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations.

Marzolf G, Sabou M, Lannes B, Cotton F, Meyronet D, Galanaud D, Cottier JP, Grand S, Desal H, Kreutz J, Schenck M, Meyer N, Schneider F, Dietemann JL, Koob M, Herbrecht R, Kremer S.

PLoS One. 2016 Apr 20;11(4):e0152475. doi: 10.1371/journal.pone.0152475. eCollection 2016.

34.

Characteristics of gliomas in patients with somatic IDH mosaicism.

Bonnet C, Thomas L, Psimaras D, Bielle F, Vauléon E, Loiseau H, Cartalat-Carel S, Meyronet D, Dehais C, Honnorat J, Sanson M, Ducray F.

Acta Neuropathol Commun. 2016 Mar 31;4:31. doi: 10.1186/s40478-016-0302-y.

35.

Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation.

Ronsin S, Deiana G, Geraldo AF, Durand-Dubief F, Thomas-Maisonneuve L, Formaglio M, Desestret V, Meyronet D, Nighoghossian N, Berthezène Y, Honnorat J, Ducray F.

Neurology. 2016 Mar 8;86(10):912-9. doi: 10.1212/WNL.0000000000002444. Epub 2016 Feb 5.

36.

Molecular heterogeneity of glioblastomas: does location matter?

Denicolaï E, Tabouret E, Colin C, Metellus P, Nanni I, Boucard C, Tchoghandjian A, Meyronet D, Baeza-Kallee N, Chinot O, Figarella-Branger D.

Oncotarget. 2016 Jan 5;7(1):902-13. doi: 10.18632/oncotarget.6433.

37.

Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome.

Laurencin C, André-Obadia N, Camdessanché JP, Mauguière F, Ong E, Vukusic S, Peter-Derex L, Meyronet D, Bouhour F, Vial C, Ducray F, Honnorat J, Petiot P.

Neurology. 2015 Dec 8;85(23):2076-8. doi: 10.1212/WNL.0000000000002037. Epub 2015 Sep 23. No abstract available.

PMID:
26400578
38.

CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.

Moutal A, Honnorat J, Massoma P, Désormeaux P, Bertrand C, Malleval C, Watrin C, Chounlamountri N, Mayeur ME, Besançon R, Naudet N, Magadoux L, Khanna R, Ducray F, Meyronet D, Thomasset N.

Cancer Res. 2015 Sep 1;75(17):3519-28. doi: 10.1158/0008-5472.CAN-14-0631. Epub 2015 Jun 29.

39.

CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.

Viaccoz A, Ducray F, Tholance Y, Barcelos GK, Thomas-Maisonneuve L, Ghesquières H, Meyronet D, Quadrio I, Cartalat-Carel S, Louis-Tisserand G, Jouanneau E, Guyotat J, Honnorat J, Perret-Liaudet A.

Neuro Oncol. 2015 Nov;17(11):1497-503. doi: 10.1093/neuonc/nov092. Epub 2015 May 25.

40.

The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study.

Meyronet D, Dorey A, Massoma P, Rey C, Alix E, Silva K, Perrin C, Quadrio I, Perret-Liaudet A, Streichenberger N, Thomasset N, Honnorat J, Arzberger T, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):975-91. doi: 10.1007/s00702-015-1378-4. Epub 2015 May 16.

PMID:
25976431
41.

Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy.

Rivera LB, Meyronet D, Hervieu V, Frederick MJ, Bergsland E, Bergers G.

Cell Rep. 2015 Apr 28;11(4):577-91. doi: 10.1016/j.celrep.2015.03.055. Epub 2015 Apr 16.

42.

Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.

Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, Quadrio I.

JAMA Neurol. 2015 Mar;72(3):267-75. doi: 10.1001/jamaneurol.2014.4068.

PMID:
25559883
43.

Erratum to: Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.

Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Revesz T, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):973-4. doi: 10.1007/s00702-014-1337-5. No abstract available.

PMID:
25418279
44.

COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse model.

Garin D, Virgone-Carlotta A, Gözel B, Oukhatar F, Perret P, Marti-Battle D, Touret M, Millet P, Dubois-Dauphin M, Meyronet D, Streichenberger N, Laferla FM, Demeunynck M, Chierici S, Sallanon Moulin M, Ghezzi C.

J Neurochem. 2015 Mar;132(5):609-18.

45.

Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.

Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Revesz T, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):957-72. doi: 10.1007/s00702-014-1304-1. Epub 2014 Sep 20. Erratum in: J Neural Transm (Vienna). 2015 Jul;122(7):973-4.

46.

[National network of paediatric central nervous system tumours reviewing by the Groupe d'Étude de Neuropathologie Oncologique Pediatrique (GENOP)].

Meyronet D, Silva K, Figarella-Branger D, Godfraind C, Delisle MB, Maurage CA, Miquel C, Varlet P, Gentet JC, Salamon AI, Vasiljevic A, Jouvet A.

Ann Pathol. 2014 Feb;34(1):74-86. doi: 10.1016/j.annpat.2014.01.002. Epub 2014 Feb 20. French.

PMID:
24630640
47.

Patterns of care and survival of glioblastoma patients: a comparative study between 2004 and 2008 in Lyon, France.

Badaoui N, Meyronet D, Cartalat-Carel S, Guyotat J, Jouanneau E, d'Hombres A, Sunyach MP, Jouvet A, Louis-Tisserand G, Archinet A, Frappaz D, Bauchet L, Honnorat J, Ducray F.

Rev Neurol (Paris). 2014 Mar;170(3):222-7. doi: 10.1016/j.neurol.2013.09.007. Epub 2014 Feb 25.

PMID:
24582303
48.

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.

Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, Luu B, Jones DT, Garzia L, Dubuc AM, Zhukova N, Vanner R, Kros JM, French PJ, Van Meir EG, Vibhakar R, Zitterbart K, Chan JA, Bognár L, Klekner A, Lach B, Jung S, Saad AG, Liau LM, Albrecht S, Zollo M, Cooper MK, Thompson RC, Delattre OO, Bourdeaut F, Doz FF, Garami M, Hauser P, Carlotti CG, Van Meter TE, Massimi L, Fults D, Pomeroy SL, Kumabe T, Ra YS, Leonard JR, Elbabaa SK, Mora J, Rubin JB, Cho YJ, McLendon RE, Bigner DD, Eberhart CG, Fouladi M, Wechsler-Reya RJ, Faria CC, Croul SE, Huang A, Bouffet E, Hawkins CE, Dirks PB, Weiss WA, Schüller U, Pollack IF, Rutkowski S, Meyronet D, Jouvet A, Fèvre-Montange M, Jabado N, Perek-Polnik M, Grajkowska WA, Kim SK, Rutka JT, Malkin D, Tabori U, Pfister SM, Korshunov A, von Deimling A, Taylor MD.

Acta Neuropathol. 2013 Dec;126(6):917-29. doi: 10.1007/s00401-013-1198-2. Epub 2013 Oct 31.

49.

Two-peaked 5-ALA-induced PpIX fluorescence emission spectrum distinguishes glioblastomas from low grade gliomas and infiltrative component of glioblastomas.

Montcel B, Mahieu-Williame L, Armoiry X, Meyronet D, Guyotat J.

Biomed Opt Express. 2013 Apr 1;4(4):548-58. doi: 10.1364/BOE.4.000548. Epub 2013 Mar 13.

50.

Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation.

Brot S, Malleval C, Benetollo C, Auger C, Meyronet D, Rogemond V, Honnorat J, Moradi-Améli M.

Exp Cell Res. 2013 Mar 10;319(5):588-99. doi: 10.1016/j.yexcr.2012.12.011. Epub 2013 Jan 5.

PMID:
23298946

Supplemental Content

Loading ...
Support Center